What are the payment terms?

We accept T/T, Western Union, Small-amount payment, and Money Gram.

What is the lead time for orders?

Off-season lead time is within 15 workdays, while peak season lead time is one month.

Do you offer customized production?

Yes, we offer customized production of generics as part of our main product services.

Clindamycin Phosphate Injection 2ml: 0.3G

Name: Clindamycin Phosphate Injection 2ml: 0.3G
Brand: Guangzhou Sinolead Biotech Co., Ltd.
SKU: 2124062545

Guangdong, ChinaGuangzhou Sinolead Biotech Co., Ltd.

US$0.10

30,000 Pieces

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Package

5AMP/Box

Composition

Clindamycin Phosphate

Model NO.

2ml: 0.3g

Transport Package

Free

Specification

2ml: 0.3g

Trademark

Sinolead

Origin

China

Key features

Water-Soluble Derivative: Formulated as an injectable solution for intravenous or intramuscular administration.

Broad-Spectrum Indications: Treats severe bacterial infections including skin, abdominal, gynecological, and respiratory infections.

Mechanism of Action: Binds to 50S ribosomal subunit to inhibit protein synthesis and cause bacterial cell death.

Professional Administration: Administered intravenously or intramuscularly by healthcare professionals.

Customized Generic Production: Company offers customized production of generic pharmaceutical products.

Flexible Payment Terms: Accepts T/T, Western Union, Small-amount payment, and Money Gram.

Global Market Reach: Exports to North America, South America, Europe, Asia, Africa, Oceania, and Middle East.

Fast Lead Time: Off-season lead time within 15 workdays; peak season lead time one month.

Company profile

Importers and Exporters

Guangzhou Sinolead Biotech Co., Ltd.

Guangdong, China

Business Type: Manufacturer/Factory, Trading Company, Group CorporationExport Year: 2005-06-16Nearest Port: Guangzhou, Shenzhen, Hong KongAverage Response Time: ≤15hTerms of Payment: T/T, Western Union, Small-amount payment, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, EXW

AI-Powered supplier vetting

SummaryThe supplier is a pharmaceutical and healthcare product manufacturer with products including glutathione, ceftriaxone sodium, amoxicillin/clavulanate, and customized generics. It reports multiple management, quality, environmental, occupational safety, and pharmaceutical certifications, along with 50 R&D engineers and 50 quality-control staff. Production information confirms several pharmaceutical dosage forms, but does not provide a directly comparable capacity figure. The supplier supports sample-based, flexible, and minor customization, but explicitly lacks ODM services, SDK availability, and recent new-product development. Service procedures exist for supplier approval, assessment, and corrective actions, although records are incomplete; complaint handling has both a clear procedure and follow-up records. It has no overseas warehouse, showroom, agents, branches, or offline trade-show experience. The company states that it has registered hundreds of pharmaceutical and healthcare products worldwide and...

Supplier typeThe supplier is positioned as a pharmaceutical and healthcare manufacturer, with listed products such as injectable ceftriaxone, glutathione, oral suspension, and customized generics. Its stated activities also include supporting product registration and regulatory dossier compliance, indicating a manufacturing-oriented pharmaceutical supplier rather than a general trading-only provider.

CertificationsThe supplier lists a broad range of certifications and management-system standards, including GMP, ISO 9001, ISO 14001, ISO 14000, HACCP, BSCI, OHSAS/OHSMS 18001, and others. The slice identifies certification holdings but does not provide certificate numbers, validity periods, or scope details.

After-Sales capabilityThe supplier has a clear complaint-handling procedure with followed records, and it accepts multiple service quotation and payment terms with stated lead times within 15 working days in both peak and off-season. However, it has no overseas warehouse, showroom, overseas agents or branches, and has no overseas-service country coverage, limiting evidence of localized after-sales support.

R&D capabilityThe supplier reports 50 R&D engineers, but explicitly states that it had no new products during the past year and no available SDK. It also does not provide ODM services, so the evidence shows established R&D staffing but limited demonstrated recent innovation.

Production capacityThe supplier lists production of multiple pharmaceutical products and dosage forms, including tablets, injections, and oral suspension, and identifies pharmaceuticals and customized generics among its product keywords. It also reports 50 quality-control staff, but the provided production-output statement is not a directly usable capacity metric for comparison.

Customization capabilityThe supplier explicitly offers customization from samples, flexible customization, and minor customization. This supports tailored production, although the supplier separately states that it does not provide ODM services.

Product Q&A

Q:What is the dosage and administration method?

It is administered intravenously or intramuscularly by a healthcare professional. Dosage depends on infection type, severity, age, weight, and renal function.

Q:What infections does this drug treat?

It treats severe bacterial infections including serious skin and soft tissue infections, intra-abdominal infections, gynecological infections, respiratory tract infections, and septicemia.

Q:How does Clindamycin Phosphate Injection work?

It acts by binding to the 50S ribosomal subunit of bacteria, inhibiting protein synthesis and ultimately leading to bacterial cell death.

Q:Are there any precautions before use?

Healthcare providers must assess medical history, allergies, and infection susceptibility. Close monitoring for adverse effects like hypersensitivity or CDAD is essential.

Q:What is the package specification?

The product comes in a package of 5 Ampoules per box.